Picture of Sihuan Pharmaceutical Holdings logo

460 Sihuan Pharmaceutical Holdings Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Annual cashflow statement for Sihuan Pharmaceutical Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M
Source:ARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinal
fx
Preliminary
Net Income/Starting Line-2,467766486-2,123
Depreciation
Amortisation
Non-Cash Items3,880-1852911,819
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-344-624-414-11.6
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities1,41822766546.5
Capital Expenditures-590-581-726-594
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items1,142-344388-1,067
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities552-925-338-1,661
Financing Cash Flow Items132905860924
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-168185751-239
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1,802-5131,078-1,854